Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma.
about
HEDD: the human epigenetic drug databaseTriplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials.Panobinostat for the treatment of acute myelogenous leukemia.Multiple myeloma: managing a complex blood cancer.Effects of Histone Deacetylase Inhibitor Panobinostat (LBH589) on Bone Marrow Mononuclear Cells of Relapsed or Refractory Multiple Myeloma Patients and Its Mechanisms.Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status.
P2860
Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma.
@en
type
label
Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma.
@en
prefLabel
Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma.
@en
P2860
P1433
P1476
Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma.
@en
P2093
Sarah L Greig
P2860
P2888
P304
P356
10.1007/S11523-015-0413-6
P577
2016-01-29T00:00:00Z
P6179
1041388443